London [UK]/Mumbai (Maharashtra) [India], March 11 (ANI/PRNewswire): Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformite Europeenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management.
Washington [US], February 13 (ANI): A new study from Washington University School of Medicine in St. Louis demonstrates that a liquid biopsy examining blood or urine can help gauge the effectiveness of therapy for colorectal cancer that has just begun to spread beyond the original tumour.
London [UK], November 9 (ANI/PRNewswire): A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy) can accurately differentiate between non-cancerous tumors versus cancerous gr
Washington DC [USA], April 17 (ANI): In a multidisciplinary study, researchers have found that a blood test may be able to detect the most common form of pancreatic cancer when it is still in its early stages, while also helping doctors accurately stage a patient's disease and guide them to
Washington D.C. [USA], Mar 5 (ANI): In a breakthrough study, researchers found that using a combination of magnetic resonance imaging (MRI) along with a standard prostate biopsy is significantly more likely to detect the most aggressive prostate cancers.
Washington D.C. [USA], Feb 29 (ANI): Researchers have made considerable advancement towards the development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Washington D.C. [USA], Feb 28 (ANI): Considerable advancement has been made by researchers at the Johns Hopkins Kimmel Cancer Center toward the development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Washington D.C. [USA], Sept 7 (ANI): Researchers discovered that modern machine learning, a branch of artificial intelligence may augment the traditional way of diagnosing kidney disease.
Washington D.C. [USA], Jun 8 (ANI): In a major relief to paediatric Non-Alcoholic Fatty Liver Disease (NAFLD) patients, a new blood test could become clinical practice within five years, reducing the need for a liver biopsy in the patients.
Washington D.C. [USA], May 24 (ANI): A recent study shows a multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy up to 67percent.